The authors reply

New England Journal of Medicine

Volumn 360, Issue 16, 2009, Pages 1677-1678

  Weinstein, Robert S ^a   Roberson, Paula K ^a   Manolagas, Stavros C ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; PLACEBO;

BONE DENSITY; BONE EROSION; CLINICAL TRIAL; DRUG EFFECT; GIANT CELL; HUMAN; LETTER; LONG TERM CARE; MORPHOMETRICS; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PAGET BONE DISEASE; PRIORITY JOURNAL;

EID: 65949113154     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. Chavassieux PM, Arlot ME, Reda C, Wei L, Yates AJ, Meunier PJ. Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis. J Clin Invest 1997;100:1475-1480 (Pubitemid 27425772)
2. Reid IR, Nicholson GC, Weinstein RS, et al. Biochemical and radiologic improvement in Paget's disease of bone treated with alendronate: a randomized, placebo-controlled trial. Am J Med 1996;101:341-348 [Erratum, Am J Med 1997;102:322.]
3. Kahn AJ, Simmons DJ. Investigation of cell lineage in bone using a chimera of chick and quail embryonic tissue. Nature 1975;258:325-327
4. Mundy GR. Bone remodeling and its disorders. London: Martin Dunitz, 1995:18-19
5. Jilka RL, Bellido T, Almeida M, et al. Apoptosis in bone cells. In: Bilezikian JP, Raisz LG, Martin TJ, eds. Principles of bone biology. 3rd ed. Vol.1. San Diego, CA: Academic Press, 2008:235-259